⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13733831 | 0.77 | — | — | |
| SCHEMBL5058344 | 0.77 | EGLN1 (0.35) | — | |
| SCHEMBL560738 | 0.76 | — | — | |
| SCHEMBL5060575 | 0.75 | GRM8 (0.38) | — | |
| SCHEMBL5488569 | 0.74 | — | — | |
| SCHEMBL28292374 | 0.74 | MEN1 (0.50) | — | |
| SCHEMBL3457874 | 0.74 | — | — | |
| SCHEMBL28695264 | 0.74 | MEN1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL27933376 | 0.74 | MEN1 (0.50) | — | |
| SCHEMBL4475592 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735603-A2 | GUIDE RNA COMPOSITIONS | nChroma Bio, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090528-A2 | CIRCULARLY STRUCTURED GUIDE RNAS FOR CRISPR GENOME EDITING | UNIVERSITY OF MASSACHUSETTS (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4720304-A2 | IMPROVED MODULAR PRIME EDITING WITH MODIFIED EFFECTORS AND TEMPLATES | University of Massachusetts (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4713458-A2 | COMPOSITIONS AND METHODS FOR REGULATING EXPRESSION OF ATXN2 | Riboway Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4709860-A1 | COMPOSITIONS AND METHODS FOR IMPROVED GENOME EDITING WITH NME2CAS9 AND NME2-SMUCAS9 VARIANTS | University of Massachusetts (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260009032-A1 | ANTI-C9ORF72 OLIGONUCLEOTIDES AND RELATED METHODS | UNIV MASSACHUSETTS (US) | 2026-01-08 | — | — | US | claimed |
| US-20250320496-A1 | MODULATION OF ABCB11 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS | CAMP4 THERAPEUTICS CORPORATION | 2025-10-16 | — | — | US | claimed |
| EP-4627084-A1 | MODULATION OF SYNGAP1 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS | Camp4 Therapeutics Corporation (US) | 2025-10-08 | — | — | EP | claimed |
| US-20250290072-A1 | MODULATION OF SYNGAP1 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS | CAMP4 THERAPEUTICS CORPORATION | 2025-09-18 | — | — | US | claimed |
| EP-4605534-A1 | CONJUGATES OF SIRNA AND ANTISENSE OLIGONUCLEOTIDES (SIRNASO) AND METHODS OF USE IN GENE SILENCING | University of Massachusetts (US) | 2025-08-27 | — | — | EP | claimed |
| WO-2017091630-A1 | TRACKING AND MANIPULATING CELLULAR RNA VIA NUCLEAR DELIVERY OF CRISPR/CAS9 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-01 | — | — | WO | claimed |
| US-20170058298-A1 | COMPOUNDS AND METHODS FOR CRISPR/CAS-BASED GENOME EDITING BY HOMOLOGOUS RECOMBINATION | AGILENT TECHNOLOGIES, INC. | 2017-03-02 | — | — | US | claimed |
| US-20160289675-A1 | Guide RNA with chemical modifications | AGILENT TECHNOLOGIES, INC. | 2016-10-06 | — | — | US | claimed |
| US-20160215275-A1 | Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents | ZHONG MINGHONG (US) | 2016-07-28 | — | — | US | claimed |
| WO-2016089433-A1 | GUIDE RNA WITH CHEMICAL MODIFICATIONS | AGILENT TECHNOLOGIES, INC. (US) | 2016-06-09 | — | — | WO | claimed |
| US-9181551-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2015-11-10 | — | — | US | claimed |
| US-20150291957-A1 | METHODS AND COMPOSITIONS TO PRODUCE ss-RNAi ACTIVITY WITH ENHANCED POTENCY | SMITH LARRY J (US) | 2015-10-15 | — | — | US | claimed |
| US-20150267200-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2015-09-24 | — | — | US | claimed |
| WO-2014066915-A2 | METHODS AND COMPOSITIONS TO PRODUCE SS-RNAI ACTIVITY WITH ENHANCED POTENCY | SMITH LARRY J (US) | 2014-05-01 | — | — | WO | claimed |
| US-20100015708-A1 | RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF | MDRNA, INC. (US) | 2010-01-21 | — | — | US | claimed |